triazoles has been researched along with Cataract, Membranous in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bardou-Jacquet, E; Beaumont-Epinette, MP; Ben Ali, Z; Brissot, P; Jouanolle, AM; Loreal, O | 1 |
| Ford, JM; Rojkjaer, L | 1 |
| Colby, KA; Mandell, KJ | 1 |
| Arpa, P; Azzolini, M; De Molfetta, V; Masera, G; Masera, N; Rescaldani, C; Tavecchia, L; Vimercati, C | 1 |
| Tanaka, KR | 1 |
1 review(s) available for triazoles and Cataract, Membranous
| Article | Year |
|---|---|
Non-HFE hemochromatosis: pathophysiological and diagnostic aspects.
Topics: Alcohol Drinking; Benzoates; Biopsy; Cataract; Cation Transport Proteins; Decision Trees; Deferasirox; Diet; Gaucher Disease; Genetic Testing; Hemochromatosis; Hemochromatosis Protein; Hepcidins; Histocompatibility Antigens Class I; Humans; Inflammation; Iron; Iron Chelating Agents; Iron Metabolism Disorders; Iron Overload; Liver; Macrophage Activation Syndrome; Magnetic Resonance Imaging; Membrane Proteins; Metabolic Syndrome; Mutation; Phlebotomy; Receptors, Transferrin; Transferrin; Triazoles | 2014 |
1 trial(s) available for triazoles and Cataract, Membranous
| Article | Year |
|---|---|
Development of lens opacities with peculiar characteristics in patients affected by thalassemia major on chelating treatment with deferasirox (ICL670) at the Pediatric Clinic in Monza, Italy.
Topics: Adolescent; Adult; Benzoates; beta-Thalassemia; Cataract; Child; Child, Preschool; Deferasirox; Humans; Iron Chelating Agents; Italy; Time Factors; Triazoles | 2008 |
3 other study(ies) available for triazoles and Cataract, Membranous
| Article | Year |
|---|---|
Comment to: Development of lens opacities with peculiar characteristics in patients affected by thalassemia major on chelating treatment with deferasirox. Haematologica 2008;93:e9-10.
Topics: Benzoates; beta-Thalassemia; Cataract; Deferasirox; Humans; Iron Chelating Agents; Research Design; Sample Size; Triazoles | 2008 |
Penetrating keratoplasty for invasive fungal keratitis resulting from a thorn injury involving Phomopsis species.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Ascomycota; Cataract; Cataract Extraction; Corneal Ulcer; Eye Infections, Fungal; Eye Injuries, Penetrating; Gardening; Humans; Keratitis; Keratoplasty, Penetrating; Male; Middle Aged; Plant Diseases; Postoperative Care; Pyrimidines; Reoperation; Triazoles; Voriconazole | 2009 |
Introduction to discussion of glucose-6-phosphate dehydrogenase deficiency.
Topics: Age Factors; Anemia, Hemolytic, Congenital Nonspherocytic; Animals; Ascorbic Acid; Black People; Blood Transfusion; Catalase; Cataract; Cats; Cattle; Dogs; Erythrocytes; Female; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Haplorhini; Humans; Hydrogen Peroxide; Lens, Crystalline; Oxygen Consumption; Pregnancy; Rabbits; Triazoles | 1971 |